Brief: Palisade Bio Provides Update On Progress Toward Launch Of Phase 1 Human Clinical Study For Lead Program, Pali-2108 For The Treatment Of Ulcerative Colitis

Palisade Bio

25/09/2024 13:03

Sept 25 (Reuters) - Palisade Bio Inc  PALI.O :
    * PALISADE BIO PROVIDES UPDATE ON PROGRESS TOWARD LAUNCH OF
PHASE
1 HUMAN CLINICAL STUDY FOR LEAD PROGRAM, PALI-2108 FOR THE
TREATMENT OF ULCERATIVE COLITIS
    * PALISADE BIO:  ON TRACK TOWARDS CLINICAL SITE INITIATION
AND
DOSING OF FIRST PATIENT IN PHASE 1 HUMAN CLINICAL STUDY BEFORE
YEAR END

Source text for Eikon:  ID:nGNX3zNyLZ 
Further company coverage:  PALI.O 

 ((Reuters.Briefs@thomsonreuters.com;))